Leerink Partnrs Expects Weaker Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Research analysts at Leerink Partnrs cut their Q4 2024 earnings per share estimates for DENTSPLY SIRONA in a research report issued to clients and investors on Thursday, November 7th. Leerink Partnrs analyst M. Cherny now anticipates that the medical instruments supplier will post earnings per share of $0.44 for the quarter, down from their previous forecast of $0.58. Leerink Partnrs currently has a “Hold” rating on the stock. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s Q1 2025 earnings at $0.40 EPS, Q2 2025 earnings at $0.50 EPS, Q3 2025 earnings at $0.54 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $1.98 EPS, FY2026 earnings at $2.32 EPS and FY2027 earnings at $2.60 EPS.

A number of other equities research analysts also recently issued reports on XRAY. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday. Barrington Research reduced their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday. Finally, Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $17.65 on Monday. The company has a market capitalization of $3.58 billion, a PE ratio of -8.53, a price-to-earnings-growth ratio of 0.97 and a beta of 1.02. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $37.60. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.87 and a current ratio of 1.25. The company’s fifty day moving average price is $24.52 and its 200-day moving average price is $25.74.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 EPS.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Raymond James Trust N.A. boosted its stake in shares of DENTSPLY SIRONA by 4.9% in the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock worth $241,000 after acquiring an additional 453 shares during the last quarter. State of Alaska Department of Revenue grew its holdings in shares of DENTSPLY SIRONA by 2.4% during the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after buying an additional 560 shares in the last quarter. LRI Investments LLC lifted its stake in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 564 shares in the last quarter. Diversified Trust Co boosted its position in DENTSPLY SIRONA by 3.0% during the second quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock worth $489,000 after acquiring an additional 566 shares during the last quarter. Finally, Allworth Financial LP grew its stake in DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 625 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.